Conference
Clinical experience with Cerebrolysin®
Abstract
Cerebrolysin® is a peptidergic drug which displays neurotrophic action in various animal models. It is used for the treatment of dementia and in this report we provide evidence for the long-term clinical efficacy of Cerebrolysin® in Alzheimer’s disease. This evidence is based on our clinical experience with Cerebrolysin®, stemming from our participation in a double- blind, placebo-controlled clinical trial, a compassionate use programme …
Authors
Molloy W; Standish TI
Pagination
pp. 293-300
Publisher
Springer Nature
Publication Date
2000
DOI
10.1007/978-3-7091-6781-6_31